Authors:
Urena, PE
Lamas, GA
Mitchell, G
Flaker, GC
Smith, SC
Wackers, FJ
McEwan, P
Pfeffer, MA
Citation: Pe. Urena et al., Ejection fraction by radionuclide ventriculography and contrast left ventriculogram - A tale of two techniques, J AM COL C, 33(1), 1999, pp. 180-185
Authors:
Bart, BA
Ertl, G
Held, P
Kuch, J
Maggioni, AP
McMurray, J
Michelson, EL
Rouleau, JL
Stevenson, LW
Swedberg, K
Young, JB
Yusuf, S
Sellers, MA
Granger, CB
Califf, RM
Pfeffer, MA
Citation: Ba. Bart et al., Contemporary management of patients with left ventricular systolic dysfunction - Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry, EUR HEART J, 20(16), 1999, pp. 1182-1190
Authors:
Domanski, MJ
Davis, BR
Pfeffer, MA
Kastantin, M
Mitchell, GF
Citation: Mj. Domanski et al., Isolated systolic hypertension - Prognostic information provided by pulse pressure, HYPERTENSIO, 34(3), 1999, pp. 375-380
Authors:
Plehn, JF
Davis, BR
Sacks, FM
Rouleau, JL
Pfeffer, MA
Bernstein, V
Cuddy, TE
Moye, LA
Piller, LB
Rutherford, J
Simpson, LM
Braunwald, E
Citation: Jf. Plehn et al., Reduction of stroke incidence after myocardial infarction with pravastatin- The cholesterol and recurrent events (CARE) study, CIRCULATION, 99(2), 1999, pp. 216-223
Authors:
Sacks, FM
Pfeffer, MA
Braunwald, E
Goldberg, RB
Mellies, MJ
Moye, LA
Davis, BR
Howard, BV
Howard, WJ
Cole, TG
Citation: Fm. Sacks et al., Baseline cholesterol level and magnitude of coronary event reduction in diabetic patients with myocardial infarction - Response, CIRCULATION, 100(25), 1999, pp. E154-E154
Authors:
Goldberg, RB
Mellies, MJ
Sacks, FM
Moye, LA
Howard, BV
Howard, WJ
Davis, BR
Cole, TG
Pfeffer, MA
Braunwald, E
Citation: Rb. Goldberg et al., Cardiovascular events and their reduction with pravastatin in diabetic andglucose-intolerant myocardial infarction survivors with average cholesterol levels - Subgroup analyses in the cholesterol and recurrent events (CARE)trial, CIRCULATION, 98(23), 1998, pp. 2513-2519
Citation: Sd. Solomon et Ma. Pfeffer, Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today, AM HEART J, 136(6), 1998, pp. 931-933